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Highlights 
 Identification of two new serovars of Actinobacillus pleuropneumoniae 
 Serological confirmation of specific reactivity with homologous antisera 
 Characterization of the capsule loci of serovars 17 and 18 
 Development of PCRs for molecular diagnostics 
 
 
Abstract 
The aim of this study was to investigate isolates of Actinobacillus 
pleuropneumoniae previously designated serologically either as NT or as ‘K2:07’, 
which did not produce serovar-specific amplicons in PCR assays.  
We used whole genome sequencing to identify the capsule (CPS) loci of six 
previously designated biovar 1 non-typable (NT) and two biovar 1 ‘K2:O7’ isolates of 
A. pleuropneumoniae from Denmark, as well as a recent biovar 2 NT isolate from 
Canada. All of the NT isolates have the same six-gene type I CPS locus, sharing 
common cpsABC genes with serovars 2, 3, 6, 7, 8, 9, 11 and 13. The two ‘K2:O7’ 
isolates contain a unique three-gene type II CPS locus, having a cpsA gene similar 
to that of serovars 1, 4, 12, 14 and 15. The previously NT isolates share the same O-
antigen genes, found between erpA and rpsU, as serovars 3, 6, 8, and 15. Whereas 
the ‘K2:O7’ isolates, have the same O-antigen genes as serovar 7, which likely 
contributed to their previous mis-identification. All of the NT and ‘K2:O7’ isolates 
have only the genes required for production of ApxII (apxIICA structural genes, and 
apxIBD export genes). 
Rabbit polyclonal antisera raised against representative isolates with these 
new CPS loci demonstrated distinct reactivity compared to the 16 known serovars. 
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The serological and genomic results indicate that the isolates constitute new 
serovars 17 (previously NT) and 18 (previously ‘K2:O7’). Primers designed for 
amplification of specific serovar 17 and 18 sequences for molecular diagnostics will 
facilitate epidemiological tracking of these two new serovars of A. 
pleuropneumoniae. 
 
Keywords: Actinobacillus pleuropneumoniae; serovar 17; serovar 18; capsule 
genes; diagnostics; PCR 
 
1. Introduction 
Actinobacillus pleuropneumoniae is a member of the Pasteurellaceae family, 
and an important respiratory pathogen of swine. Economic losses in the swine 
industry worldwide are due to mortality associated with acute disease, and the 
medication cost for treatment and reduced production associated with chronic 
pleuropneumonia (Sassu et al., 2017). Approaches to controlling the disease include 
good husbandry/biosecurity and vaccination to reduce incidence, and in the face of 
clinical disease, treatment with antibiotics to limit severity and spread (Sassu et al., 
2017). 
It is useful to classify isolates of A. pleuropneumoniae not only for 
epidemiological purposes, but also to inform vaccine development (Gottschalk, 
2012). Broadly, isolates can be separated into two biovars, with the more prevalent 
biovar 1 type requiring exogenous nicotinamide adenine dinucleotide (NAD) for 
growth, and biovar 2 being NAD-independent (Pohl et al., 1983; Maldonado et al., 
2009). Isolates can be further differentiated into serovars, based mainly on capsular 
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antigens (Perry et al., 1990; Dubreuil et al., 2000), and 16 serovars are currently 
recognized (Sárközi et al., 2015; Bossé et al., 2017a). 
With improved molecular diagnostics, including whole genome sequencing, it 
is possible to re-evaluate previously non-typable (NT) isolates, as well as isolates 
which present unusual serological or molecular diagnostic results. Recently, Morioka 
et al. (2016) showed that the methods of antigen preparation and serological testing, 
could influence the results for identification of certain serovars. Specifically, 
autoclaved antigens of forty-seven isolates proved un-typable in the agar gel 
diffusion assay, whereas rapid slide agglutination using formalin-fixed antigens 
identified all but two isolates as serovars 1, 2 or 15. The capsule types were 
confirmed by multiplex PCRs (mPCRs) (Bossé et al., 2014; Turni et al., 2014; Ito, 
2010), with the two remaining serologically NT isolates producing specific amplicons 
for serovars 2 and 15. Not all isolates of a given serovar were identified by all of the 
available mPCRs. The reason for the discrepancy between molecular and 
serological typing for these two isolates was not investigated; however it is possible 
that the presence of a transposon insertion in the CPS loci resulted in no 
serologically detectable capsule being produced. This was recently shown by Ito et 
al. (2016) who found that the presence of ISAplI insertions in the CPS loci of two 
isolates with serovar 15-specific capsule genes rendered them serologically NT.  
The aim of this study was to investigate isolates of A. pleuropneumoniae 
previously designated serologically either as NT or as ‘K2:07’, but which did not 
amplify serovar-specific amplicons in mPCRs (Jessing et al., 2003; Schuchert et al., 
2004; Angen et al., 2008), by whole genome sequencing in order to determine the 
molecular organization of their CPS biosynthetic loci. Our results demonstrate the 
existence of two new serovars, 17 and 18, of A. pleuropneumoniae. 
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 2. Materials and Methods 
 
2.1 Clinical A. pleuropneumoniae isolates used in this study 
 Information regarding the proposed serovar 17 and 18 A. pleuropneumoniae 
isolates sequenced in this study is shown in Table 1. The Danish biovar 1 isolates 
previously designated as serologically NT were shown to belong to a distinct 
phylogenetic cluster (c17) by amplified fragment length polymorphism (AFLP), and 
were all recovered from pigs on the same farm (Kokotovic and Angen, 2007). Those 
designated as ‘K2:O7’ (also biovar 1) had been typed serologically by latex 
agglutination, but showed no serovar-specific bands when tested by mPCR (Angen 
et al., 2008; Bossé et al., 2014; Jessing et al., 2003; Schuchert et al., 2004). The 
Canadian biovar 2 isolate, 14-022, recovered from the pneumonic lung of a pig in 
Ontario in 2014, was also found to be NT by serological and molecular methods 
(Bossé et al., 2014). Information regarding nine additional isolates typed as serovar 
17 or 18 by PCR is shown in Table 2. Of these, two of the ‘K2:O7’ isolates (15360/96 
and 12323/98) were previously reported to belong to the distinct AFLP phylogenetic 
cluster, c11 (Kokotovic and Angen, 2007). 
 
2.2 Genome sequencing and analysis 
 Genomic DNA was prepared from all isolates as previously described (Bossé 
et al., 2015). The Microbes NG Sequencing Facility (www.microbesng.uk) generated 
and assembled the whole genome sequence of isolate 14-022; for all other samples, 
paired-end sequencing (Illumina HiSeq 2000) was performed at the Wellcome Trust 
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Sanger Institute (Cambridge, UK), analysed, and assembled and as previously 
described (Bossé et al., 2017b; Howell et al., 2013; Weinert et al., 2015).  
Genes of the CPS biosynthetic loci were identified in the draft genomes of 
each isolate by searching, using BLASTn (http://blast.ncbi.nlm.nih.gov /Blast.cgi), for 
the cpxD gene (accession AIA09380) from the capsule export locus, common to all 
serovars. The identified loci were analyzed using BLASTn and BLASTx. Multiple 
sequence alignments were performed using ClustalW in MacVector v15.5.2. Genes 
encoding Apx toxin biosynthetic and export proteins were also identified by BLASTn 
using sequences of apxICABD and apxIICA from the L20 genome (accession 
number CP000569), and apxIIICABD from the JL03 genome (accession number 
CP000687). The O-antigen biosynthesis loci were identified by tBLASTn using the 
erpA and rpsU genes (accession numbers WP_005617946  and WP_005598703, 
respectively) to delineate the flanking genes. 
The sequences of the complete capsule loci for the serovar 17 and 18 isolates 
listed in Table 1 have been deposited in GenBank under accession numbers: 
MG780416 - MG780424. 
 
2.3 Production of antisera 
 Hyperimmune rabbit polyclonal antisera were raised against formalin-killed 
preparations of isolates 16287-1 (Danish NT; proposed reference strain for serovar 
17) and 7311555 (Danish ‘K2:O7’; proposed reference strain for serovar 18), as 
previously described (Sárközi et al., 2015). 
  
2.4 Serological testing 
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Indirect hemagglutionation (IHA) was performed using antisera raised against 
the 16 recognised serovars (Sárközi et al., 2015), as well as the new antisera raised 
in this study, as previously described (Sárközi et al., 2015). 
   
2.5 Diagnostic PCRs 
Primers AP17F (TTGTAATGGCGGTGTAATGCTAC) and AP17R 
(CATAAGTGCAGCCATCTCTTTCAG) were designed to amplify a 302 bp serovar 
17-specific amplicon; and primers AP18F (CGGAGTTTGGCAGCATAAAGG) and 
AP18R (CCATAATCGGTGCTCAACTAAGAATG) were designed to amplify a 514 bp 
fragment of the serovar 18-specific amplicon (see Fig. 1 for locations of primers). 
These primers were combined, along with those previously designed (Bossé et al., 
2014) for detection of the 418 bp apxIV band common to all serovars, and were 
initially tested using genomic DNA from the six Danish and one Canadian NT 
isolates (for serovar 17), and the two Danish ‘K2:O7’ isolates (for serovar 18), shown 
in Table 1, as well as the reference strains for the 16 known serovars strains (i.e. 
4074T, 1536, S1421, M62, K17, L20, Femø, WF83, 405, CVJ13261, D13039, 56153, 
8328, N-273, 3906, HS143, and A-85/14, respectively). Subsequently, the specificity 
of the primers was further evaluated using the same 68 clinical isolates of A. 
pleuropneumoniae (covering serovars 1-15), the six A. pleuropneumoniae serovar 
16 isolates, and the 31 porcine-associated species recently used for evaluation of 
serovar 16-specific primers (Bossé et al., 2017a), as well as the nine clinical isolates 
shown in Table 2.   
 
3. Results and Discussion  
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 The serovar 17 isolates (Table 1; proposed reference strain 16287-1) encode 
a type I CPS locus (Fig. 1A), with the first three genes (cps17ABC) encoding a 
glycerol transferase, a glycerol-3-phosphate cytidylyltransferase, and a hypothetical 
protein, respectively, with high identity to those encoded by the first three genes in 
the loci of serovars 2, 3, 6, 7, 8, 9, 11 and 13 (Xu et al., 2010; Bossé et al., 2014). 
The serovar 17 CPS locus most closely resembles that of serovar 8, with 99% 
identity at the nucleotide level between the sequences cps17ABCDE and 
cps8ABCDE (Fig. 1A). The cpsDE genes in both these serovars encode the same 
predicted glycosyltransferases. We previously reported (Bossé et al., 2014) that the 
CPS locus of the serovar 8 reference strain, 405, was comprised of these 5 genes. 
However, upon further analysis of the sequences downstream of the cpsE gene in 
the draft genome sequence of strain 405, and in the complete genome sequence of 
MIDG2331 (Bossé et al., 2016), a further three ORFs encoding hypothetical proteins 
(MIDG2331_01764, MIDG2331_01763, and MIDG2331_01762) are present that 
may also be part of the CPS biosynthetic locus, though the function of these proteins 
has yet to be determined.  
In the serovar 17 CPS locus, the first 5 genes are followed by a single ORF 
(cps17F) predicted to encode a hypothetical protein containing a DUF1919 
superfamily domain (involved in cell wall/membrane/envelope biogenesis) in the N-
terminal portion of the sequence. The first 197 amino acids (AAs) of the Cps17F 
sequence shares 54% identity with a predicted expolysaccharide biosynthesis 
protein (206 AA) encoded by a gene divergently transcribed from that encoding 
phosphomanomutase in all sequenced serovars of A. pleuropneumoniae (see 
accession number WP_005603976), including the draft genomes of the serovar 17 
and 18 isolates from this study. The C-terminal portion of the Cps17F protein (AAs 
AC
CE
PT
ED
 M
AN
US
CR
IPT
229-515) shares 94% identity with the 303 AA protein encoded by the final gene in 
the serovar 8 MIDG2331 cps locus, MIDG2331_01762 (Fig. 1), suggesting that the 
serovar 17 CPS locus may have arisen by recombination of a gene encoding a 
predicted expolysaccharide biosynthesis protein into the terminal gene of the serovar 
8 CPS locus, with deletion of the preceding two serovar 8 CPS locus genes.  
 The serovar 18 isolates (Table 1; proposed reference strain 7311555) encode 
a type II CPS locus (Fig. 1B), with the first gene encoding a phosphotransferase 
sharing high identity with that encoded by the first gene in the loci of serovars 1, 4, 
12, 14, and to a lesser extent with that of serovar 15 ( Xu et al., 2010; Ito, 2015; Ito 
and Sueyoshi, 2015). The second gene in the serovar 18 locus encodes a 1115 AA 
glycosyltransferase with only 32% identity to the 1247 AA glycosyltransferase 
encoded by the serovar 1 cpsB gene, although the first 23 AAs are identical in the 
two proteins. The final gene in the serovar 18 CPS locus encodes a 401 AA protein 
similar to the 406 AA protein encoded by the cps1C gene, though they share only 
41% identity. These proteins contain an Asp2 superfamily domain found in 
Accessory Sec system GspB-transporters of Gram positive bacteria. The serovar 18 
CspC protein shares highest identity (55% over 361 AAs) with a predicted alpha/beta 
hydrolase from Cronobacter malonaticus (accession WP_032971501), whereas the 
serovar 1 CpsC shares highest identity (68% over 387 AAs) with a predicted 
Accessory Sec system GspB-transporter from Basfia succiniciproducens (accession 
numberSEP68412). The function of these CpsC proteins has yet to be determined. 
In the serovar 1 CPS locus, there is an additional gene, cpsD, encoding a 347AA 
predicted acetyl transferase that is not present in the serovar 18 locus. 
 Results of Indirect Hemagglutination (IHA) using hyperimmune rabbit sera 
revealed homologous reactivity (titer of 2560) of the serovar 17 antiserum with the 
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proposed reference strain (16287-1), with similar titers (+/- one dilution) for other 
serovar 17 isolates, including 14-022, confirming both biovar 1 and biovar 2 isolates 
of serovar 17. Cross-reactivity (i.e. titers ≥ 640) was also detected between serovars 
17 and 8 (titer of 1280 for the serovar 17 serum tested with the serovar 8 strain; but 
only a titer of 640 for the serovar 8 serum tested with the serovar 17 strain). In 
contrast, the serovar 18 antiserum was highly specific, giving a titer of 10240 with the 
proposed reference strain 7311555. These results are not surprising given the 
genetic data showing more unique genes for the serovar 18 locus, and the shared 
genes common to the CPS loci of serovars 8 and 17.  
We identified the O-antigen genes in the sequenced serovar 17 and 18 
isolates, located between the erpA and rpsU genes, as previously reported for other 
serovars of A. pleurpneumoniae (Xu et al., 2010). BLASTn results for the serovar 17 
O-antigen genes indicated 97-100% identity (over 13600 bp) with the loci in serovars 
3, 6, 8, 15 (accession numbers CP000687, ADOG00000000, LN908249, and 
AB743837, respectively). Given that we only found serological cross-reactivity 
between serovar 17 and the serovar 8, it would appear that our IHA assay detected 
antibodies directed against CPS antigens, but not O-antigens. BLASTn analysis of 
the serovar 18 O-antigen genes revealed 97% identity (over 11340 bp) with the locus 
in serovar 7 (accession number CP001091). Again, our IHA results did not show 
cross-reactivity between serovars 18 and 7, indicating that antibodies directed 
against common O-antigens were not detected. However, it is likely that the previous 
serological designation of ‘K2:O7’ for these isolates was due to detection of O-
antigen-specific antibodies.  
 For molecular diagnostics, we designed primers to amplify a unique 302 bp 
amplicon from the serovar 17 cpsF gene, and a unique 514 bp amplicon from the 
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serovar 18 cpsB gene. When multiplexed, along with previously designed species-
specific apxIV primers for detection of all A. pleuropneumoniae serovars (Bossé et 
al., 2014), specific detection of the serovar 17 and 18 amplicons was seen with the 
respective proposed reference strains, with all of the other serovar reference strains 
only amplifying the apxIV amplicon (Fig. 2). The specificity of the serovar 17 and 18 
primers was further confirmed using the other sequenced serovar 17 and 18 isolates 
shown in Table 1, as well as DNA from clinical isolates of A. pleuropneumoniae 
representing the 16 known serovars, other bacteria associated with pigs, and by 
virtual PCR using genome sequences available in Genbank, as previously described 
(Bossé et al., 2017a).  
PCR analysis of DNA samples from the isolates shown in Table 2 revealed 
that the recent biovar 2 NT isolates from the USA typed as serovar 17, as did two of 
the recent biovar 1 Spanish isolates (4443 and 4461).  These two Spanish isolates 
were initially typed as serovar 8 by mPCR (Bossé et al., 2014), whereas all of the 
North American biovar 2 isolates were NT in this assay. These results indicate that 
some serovar 17 isolates share the cpsAB sequences targeted by what were thought 
to be serovar 8-specific primers. Thus, in the past, some serovar 17 isolates may 
have been molecularly typed as serovar 8, depending on the primers used, or 
serologically as 3/6/8 if the test used detected O-antigens. Evidence supporting 
serovar 17 as separate from serovar 8 includes the segregation of the Danish NT 
isolates by AFLP into the c17 cluster distinct from serovar 8 isolates in c5 (Kokotovic 
and Angen, 2007); the lack of apxIIIABCD genes normally found in serovar 8 (see 
below); and the presence of only six CPS biosynthetic genes compared to eight 
genes found in the CPS locus of serovar 8.  
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The previously NT isolates from Germany (2008), Italy (2011), and the two 
Spanish NT isolates (APP199 and 4436; from 2004 and 2017, respectively), typed 
as serovar 18, as did three additional ’K2:O7’ isolates collected between 1996-2002. 
These ’K2:O7’ isolates included 15360/96 and 12323/98, that had been shown to 
form a distinct AFLP cluster (c11), separate from other K2:O7 isolates found in 
cluster c8 (Kokotovic and Angen, 2007). Whereas the K2:O7 isolates in c8 were 
found to produce amplicons for serovar 2, as well as serovar 8, when tested in 
mPCRs (Jessing et al., 2003; Schuchert et al., 2004), those in c11 only produced a 
species-specific omlA amplicon (Jessing et al., 2003). The primer pair used by 
Shuchert et al. (2004) for detection of serovar 8 was designed to amplify a 977 bp 
sequence from the cpsAB genes which are common to serovars with type I CPS loci, 
with different degrees of identity at the nucleotide level; whereas the serovar 2 
primer pair amplified region spanning the cpsCD genes, the latter being less well 
conserved amongst type I CPS loci. Likewise, the serovar 2 primer pairs used by 
Jessing et al. (2003) were designed to amplify a 504 bp cpsD-specific region. Thus, 
the serovar 2 amplicon produced by the K2:O7 isolates in AFLP cluster c8 is likely 
specific for the serovar 2 CPS locus, whereas the serovar 8 amplicon is likely due to 
the presence of common priming sites in the cpsAB genes.  
The distribution of genes encoding Apx toxins I-III differ depending on 
serovar, with some biovar 2 serovars showing different Apx toxin profiles than their 
biovar 1 counterparts (Sthitmatee et al., 2003; Rayamajhi et al., 2005; Maldonado et 
al., 2009). Toxin typing PCRs have been used for characterizing isolates, since 
those producing ApxI tend to be more highly virulent (Frey et al., 1995; Sthitmatee et 
al., 2003; Rayamajhi et al., 2005; Maldonado et al., 2011). The serovar 17 and 18 
isolates sequenced in the current study, regardless of biovar, were all found to 
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harbor only the genes required for production of ApxII (apxIICA structural genes, and 
apxIBD export genes), a pattern similar to that reported for biovar 1 serovars 7 and 
12, as well as biovar 2 isolates of serovars 2, 4, 7, 11 and 13 (Frey et al., 1995; 
Rayamajhi et al., 2005; Maldonado et al., 2009; Maldonado et al., 2011). A number 
of Spanish biovar 2 NT isolates were also reported to produce only ApxII 
(Maldonado et al., 2009; Maldonado et al., 2011). Testing of these isolates with our 
new mPCR would determine if any belong to serovars 17 or 18. 
 In conclusion, we have used a combination of whole genome sequencing and 
serology to clarify the status of previously NT isolates, as well as isolates previously 
mis-typed as ‘K2:O7’ (and unreactive in previous CPS-specific mPCRs), showing 
that they represent new serovars, 17 and 18 respectively, of A. pleuropneumoniae. 
Biovar 1 isolates of serovar 17, first recovered in Denmark in 1997, appear to still be 
in circulation in Europe, with a recent (2017) isolate from Spain identified. Whereas 
biovar 2 serovar 17 isolates have been recovered in North America since 2014. 
Given the relatedness of the core cps and O-antigen genes between serovars 8 and 
17, it is possible that other isolates of serovar 17 may have been typed as serovar 8 
in the past. Serovar 18 isolates (biovar 1) have been in circulation in Europe since 
1996, most recently recovered in Spain in 2018.  The PCR primers designed in this 
study will help in further identification and epidemiological tracking of these two 
newly designated serovars of A. pleuropneumoniae. 
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Table 1. Proposed serovar 17 and 18 isolates of A. pleuropneumoniae sequenced in this study. 
Strain ID Year Country Previous 
Designation 
Biovar Proposed  
Serovar 
Reference 
16287-1 1997 Denmark NT 1 17 (Kokotovic and Angen, 2007) 
17102-11 1997 Denmark NT 1 17 (Kokotovic and Angen, 2007) 
10907-11 1998 Denmark NT 1 17 (Kokotovic and Angen, 2007) 
11990-6 1998 Denmark NT 1 17 (Kokotovic and Angen, 2007) 
11990-7 1998 Denmark NT 1 17 (Kokotovic and Angen, 2007) 
17102-10 1997 Denmark NT 1 17 (Kokotovic and Angen, 2007) 
14-022 2014 Canada NT 2 17 This study 
7311555 2001 Denmark K2:O7 1 18 This study 
7603757 2005 Denmark K2:O7 1 18 This study 
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Table 2.  Additional A. pleuropneumoniae serovar 17 and 18 isolates identified by PCR. 
Strain ID Year Country  Previous 
Designation 
Biovar Serovar 
by PCR 
Reference 
11-008-1 2008 Germany NT 1 18 This study 
1055935 2011 Italy NT 1 18 This study 
A05-0208 2016 USA NT 2 17 This study 
16-006 2016 USA NT 2 17 This study 
17-027 2017 USA NT 2 17 This study 
APP199 2004 Spain NT 1 18 This study 
4436 2017 Spain NT 1 18 This study 
4443 2017 Spain 8 1 17 This study 
4461 2018 Spain 8 1 17 This study 
15360/96 1996 Denmark K2:O7 1 18 (Kokotovic and Angen, 2007) 
12323/98 1998 Denmark K2:O7 1 18 (Kokotovic and Angen, 2007) 
10374/02 2002 Denmark K2:O7 1 18 (Kokotovic and Angen, 2007) 
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Figure 1. Schematic representations of A. pleuropneumoniae CPS biosynthetic loci. 
A) The serovar 17 type I CPS biosynthetic locus and comparison to that of the 
serovar 8 reference strain, 405. The CPS biosynthesis genes for serovar 17 (Sero 
17; cps17ABCDEF). The serovar 8 CPS biosynthetic locus shares the first 5 genes 
as the serovar 17 locus (99% identity at the nucleotide level as indicated by the grey 
box joining these genes), and contains three further genes (each labelled hyp to 
indicate that they encode hypothetical proteins), the last of which shares 91% 
identity at the nucleotide level with the 3’ end of the cps17F gene (as indicated by 
the lighter grey parallelogram). B) The serovar 18 type II CPS biosynthetic locus 
(cps18ABC) and comparison to that of the serovar 1 reference strain, 4074 
(cps1ABCD). The cpsA genes in these serovars share 99% identity at the nucleotide 
level (indicated by the grey box joining the genes), whereas the cpsBC genes share 
less than 55% identity at the nucleotide level (indicated by the pale grey trapezoid 
joining these genes). The locations of serovar 17- and 18-specific primers are 
indicated as small curved black arrows above cps17F and cps18B, respectively. The 
relative size and location of each gene are indicated by the sizes and positions of 
arrows (solid dark gray). In all loci shown here, the CPS biosynthesis genes are 
located downstream of, and on the opposite strand to, the capsule export genes 
common to the loci in all A. pleuropneumoniae serovars (cpxDCBA; only cpxD is 
shown). 
 
 
 
 
Figure 2. Verification of specificity of primers for molecular identification of A. 
pleuropneumoniae serovars 17 and 18. An apxIV (418-bp) amplicon is detected in all 
18 serovar reference strains; the serovar 17-specific amplicon (302 bp) is detected 
only in the serovar 17 isolates (lanes 17, 17a); and the serovar 18-specific amplicon 
(514 bp) is detected only in the serovar 18 isolates (lanes 18, 18a). Lane M contains 
molecular size markers (100-bp ladder). Lanes 1 to 18 contain samples from the 
following strains: 1, 4074T; 2, S1536; 3, S1421; 4, M62; 5, L20; 6, Femo; 7, WF83; 
8, 405; 9, CVJ13261; 10, D13039; 11, 56153; 12, 8329; 13, N-273; 14, 3906; 15, 
HS143; 16, A-85/14; 17, 16287-1; 18, 7311555. Lane 17a contains the biovar 2 
isolate, 14-022, showing the same serovar 17 amplicon as the biovar 1 reference 
strain and other biovar 1 clinical isolates tested. Lane 18a contains serovar 18 
isolate 7603757.  
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